Table 2

In-hospital outcomes and postprocedural echocardiographic data

Beta-blocker (+) n=779Beta-blocker (−) n=779P value
Procedural outcomes
 30-day mortality8 (1.0)14 (1.8)0.19
 Procedural MI6 (0.8)1 (0.1)0.12
 Ischaemic stroke13 (1.7)15 (1.9)0.7
 Haemorrhagic stroke1 (0.1)3 (0.4)0.32
 Bleeding190 (24.4)192 (24.6)0.91
 AKI91 (11.7)93 (11.9)0.88
 Vascular complication74 (9.5)68 (8.7)0.59
 New permanent pacemaker56 (7.2)74 (9.5)0.099
 New onset AF34 (4.4)24 (3.1)0.19
 Congestive heart failure34 (4.4)52 (6.7)0.046
Postprocedural echocardiographic data
 LVEF, %62.0 (54.0–67.0)62.1 (54.0–67.4)0.49
 LVEF <50%141 (18.3)122 (15.9)0.21
 THV peak velocity, m/s2.15 (1.90–2.47)2.20 (1.93–2.50)0.095
 THV mean pressure gradient, mm Hg9.4 (7.4–12.9)10.0 (7.3–13.0)0.13
 Indexed EOA, cm2/m21.15 (0.97–1.36)1.13 (0.95–1.31)0.13
 PPM94 (12.4)85 (11.3)0.52
PVL0.34
 None140 (18.0)127 (16.4)
 Trace366 (47.0)377 (48.6)
 Mild252 (32.4)259 (33.4)
 Moderate20 (2.6)11 (1.4)
 Severe1 (0.1)0 (0.0)
 PVL ≥ moderate20 (2.6)12 (1.5)0.16
  • AF, atrial fibrillation; AKI, acute kidney injury; EOA, effective orifice area; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PPM, prosthesis-patient mismatch; PVL, paravalvular leak; THV, transcatheter heart valve.